Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Venturia inaequalis messenger RNA (mRNA) refers to the collective set of protein-coding transcripts produced by the ascomycete fungus responsible for apple scab, one of the most economically significant diseases in global apple production (Source: Wikipedia). In the context of modern agricultural biotechnology, specific mRNA sequences within this pathogen are targeted using Spray-Induced Gene Silencing (SIGS), a form of RNA interference (RNAi) (Source: Frontiers in Plant Science, 2021). This approach involves the application of double-stranded RNA (dsRNA) molecules designed to be sequence-specific to essential fungal genes, such as those encoding lanosterol 14α-demethylase (CYP51) or chitin synthases (Source: Pest Management Science, 2023). Once the fungus takes up these dsRNA molecules, its internal RNAi machinery processes them into small interfering RNAs (siRNAs) that guide the degradation of the target mRNA (Source: Molecular Plant Pathology, 2020). The resulting loss of mRNA prevents the translation of proteins necessary for fungal survival, growth, and infection of the host plant (Source: Plants, 2022). While RNAi-based fungicides represent a highly specific and potentially sustainable alternative to traditional chemical treatments, their commercial success depends on overcoming challenges such as RNA stability in the environment and ensuring no off-target effects occur in beneficial organisms (Source: Journal of Fungi, 2021).
RNA interference (RNAi) leading to sequence-specific degradation of fungal mRNA and subsequent gene silencing.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venturia inaequalis messenger RNA (V. inaequalis mRNA).